Focusfreda successfully obtained the national invention patent and moved into a new field of health industry
Release time:
2023-09-20
Recently, Focusfreda successfully authorized a new national patented technology called "A Preparation Method and Application of Astaxanthin Hyaluronic Acid Ester and Micelles". The successful authorization of this patent is recognition of our continuous innovation and R&D capabilities, and also marks another important step for us in the big health industry.
There are currently many studies trying to combine hyaluronic acid with astaxanthin in order to improve the low bioavailability and instability of astaxanthin and broaden the application fields of hyaluronic acid so that it is no longer limited to cosmetics. "A preparation method and application of astaxanthin hyaluronic acid ester and micelles" provides a simple and effective preparation method of astaxanthin hyaluronic acid composition. The prepared product has good water solubility and high stability. , strong skin penetration, good antioxidant effect, and amphipathic. The composition itself and the micelles prepared based on it have huge application potential.
Over the years, Focus Freda has always been committed to the research and development of innovative technologies, constantly breaking through and forging ahead. At present, we have obtained more than 70 patents authorized by the State Intellectual Property Office through application. In the future, Focus Freda will continue to increase investment in research and development, continue to innovate, and create greater industrial value for our customers.
BLOGS
See You in Paris! Focusfreda Brings the "HA+" to in-cosmetics Global 2026
Join Focusfreda at in-cosmetics Global 2026 (Booth 2S59) in Paris. Discover our "HA+" philosophy and new biotech breakthroughs: Copper Lysinate Hyaluronate and Lysine Hyaluronate for sustainable, high-performance skincare.
Discover why the combination of Sodium Polyglutamate (Gamma-PGA) and Hyaluronic Acid (HA) is the new gold standard in professional skincare. Explore the science of the 3D Moisture Matrix and Focusfreda’s green bio-fermentation technology.
Explore the synergistic benefits of oral Sodium Hyaluronate and Ergothioneine (EGT). Learn how EGT stabilizes HA via the OCTN1 transporter to prevent oxidative degradation, enhancing bioavailability in next-generation longevity dietary supplements for 2026.
Good Breakthrough | FocusFreda Secures First NCI Registration for "Lysine Hyaluronate"
FocusFreda achieves a skincare milestone with the China NMPA registration of Lysine Hyaluronate (NCI No. 20260026). This innovative "Hyaluronic Acid+" ingredient combines essential amino acid for superior skin affinity, enzymatic stability, and synergistic repair. Explore how FocusFreda is leading the global shift toward high-end, science-backed green beauty solutions.
Knee osteoarthritis (KOA) is a common chronic joint disease with an increasing prevalence among older adults, severely impacting quality of life. Sodium hyaluronate (SH), as a core component of synovial fluid, is a key drug in KOA treatment. However, different molecular weights of SH exhibit significant differences in efficacy and mechanism of action, directly affecting treatment options. This article focuses on interpreting its differentiating effects to provide a reference for clinical application. [Reference Interpretation: Figure 1]
Is Hyaluronic Acid Ingredient Good for Acne? Safe Hydration for Breakout-Prone Skin
Learn whether hyaluronic acid is good for acne-prone skin, if it clogs pores, how it supports the skin barrier, and how to pair it with retinoids, niacinamide, and BHA—plus routine tips and FAQs.